Pathstone Holdings
ELV icon

Pathstone Holdings’s Elevance Health ELV Stock Holding History

Pathstone Holdings’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Buy
39,013
+7,800
+25% +$2.89M 0.04% 264
2026
Q1 		$9.14M Sell
31,213
-3,403
-10% -$1.12M 0.04% 369
2025
Q4 		$12.1M Buy
34,616
+2,268
+7% +$766K 0.05% 277
2025
Q3 		$10.5M Sell
32,348
-968
-3% -$301K 0.04% 323
2025
Q2 		$13M Sell
33,316
-1,161
-3% -$467K 0.05% 250
2025
Q1 		$15M Sell
34,477
-2,010
-6% -$807K 0.07% 229
2024
Q4 		$13.5M Sell
36,487
-6,569
-15% -$2.75M 0.06% 226
2024
Q3 		$22.4M Sell
43,056
-3,907
-8% -$2.09M 0.1% 150
2024
Q2 		$25.4M Buy
46,963
+5,341
+13% +$2.82M 0.11% 131
2024
Q1 		$21.6M Buy
41,622
+3,858
+10% +$1.92M 0.1% 140
2023
Q4 		$17.8M Buy
+37,764
New +$17.5M 0.1% 153

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pathstone Holdings's ELV Position: Q2 2026 in Review

Pathstone Holdings increased its Elevance Health (ELV) stake by 25% in Q2 2026, buying an estimated $2.89M and bringing the position to 39,013 shares worth $15.1M. The position accounts for 0.04% of the portfolio, ranked #264.

Pathstone Holdings first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. The position peaked at $25.4M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Pathstone Holdings held 39,013 shares of Elevance Health worth $15.1M as of Q2 2026.
  • Pathstone Holdings bought 7,800 Elevance Health shares in Q2 2026, an estimated $2.89M.
  • Elevance Health made up 0.04% of Pathstone Holdings's portfolio in Q2 2026, its #264 holding.
  • Pathstone Holdings first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Elevance Health position peaked at $25.4M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.